Latest News and Press Releases
Want to stay updated on the latest news?
-
Robbins LLP is Investigating Allegations that Replimune Group, Inc. (REPL) Misled Investors Regarding the Viability of its IGNYTE Trial
-
Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel
-
Robbins LLP is Investigating Allegations that Alto Neuroscience, Inc. (ANRO) Misled Investors Regarding the Viability of its Drug Candidate
-
Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
-
Robbins LLP is Investigating Allegations that Iovance Biotherapeutics, Inc. (IOVA) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Zenas BioPharma, Inc. (ZBIO) Misled Investors in Connection with its IPO
-
New York, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Helogen Corporation, a space biology and infrastructure company, today announced the acquisition of Vellon Space Private Limited, a Bengaluru,...
-
Robbins LLP is Investigating Allegations that Cerevel Therapeutics Holdings, Inc. (formerly CERE) Misled Investors Relating to the Company's October 16, 20
-
Robbins LLP is Investigating Allegations that Sana Biotechnology, Inc. (SANA) Misled Investors Regarding its Ability to Maintain Operations.
-
Robbins LLP is Investigating Allegations that Geron Corporation (GERN) Misled Investors Regarding the Launch and Potential Growth of Rytelo